Atlas Trials

Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies

Clinical trial NCT05935202 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05935202
Sponsor
EuroBloodNet Association
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hereditary Red Blood Cell Disorder (Disorder)
Start date
2023-12-21
Primary completion
2025-07-15
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.